Bioactivity:

Pradefovir is a reverse transcriptase inhibitor potentially for treatment of chronic HBV infection. Pradefovir is also a liver-targeted prodrug of adefovir. After metabolic activation, Pradefovir was converted to PMEA (9-(2-phosphonylmethoxyethyl)adenine

CAS nr:

625095-60-5

Purity:

98%

Molecular Weight:

423,79

SMILES:

ClC1=CC([C@H]2O[P@](OCC2)(COCCN3C=NC4=C(N)N=CN=C34)=O)=CC=C1

Formula:

C17H19ClN5O4P

Pathway:

Microbiology/Virology

Target:

HBV